Subscribe to RSS
DOI: 10.1055/s-0033-1350672
Structure-Activity Relationship Study of Biflavonoids on the Dengue Virus Polymerase DENV-NS5 RdRp
Publication History
received 11 March 2013
revised 30 June 2013
accepted 05 July 2013
Publication Date:
08 August 2013 (online)

Abstract
Dengue virus is the worldʼs most prevalent human pathogenic arbovirus. There is currently no treatment or vaccine, and solutions are urgently needed. We previously demonstrated that biflavonoids from Dacrydium balansae, an endemic gymnosperm from New Caledonia, are potent inhibitors of the Dengue virus NS5 RNA-dependent RNA polymerase. Herein we describe the structure-activity relationship study of 23 compounds: biflavonoids from D. balansae (1–4) and from D. araucarioides (5–10), hexamethyl-amentoflavone (11), cupressuflavone (12), and apigenin derivatives (13–23). We conclude that 1) over the four different biflavonoid skeletons tested, amentoflavone (1) and robustaflavone (5) are the most promising ones for antidengue drug development, 2) the number and position of methyl groups on the biflavonoid moiety modulate their inhibition of Dengue virus NS5 RNA-dependent RNA polymerase, and 3) the degree of oxygenation of flavonoid monomers influences their antidengue potential. Sotetsuflavone (8), with an IC50 = 0.16 µM, is the most active compound of this series and is the strongest inhibitor of the Dengue virus NS5 RNA-dependent RNA polymerase described in the literature.
Key words
biflavonoids - Dacrydium araucarioides - Dacrydium balansae - Podocarpaceae - antiviral - Dengue virus - NS5 RdRp - SAR study-
References
- 1 WHO. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: WHO Press; 2009
- 2 Massé N, Davidson A, Ferron F, Alvarez K, Jacobs M, Romette JL, Canard B, Guillemot JC. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirinʼs activity. Antiviral Res 2010; 86: 296-305
- 3 Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, De Lamballerie X, Gould EA, Grard G, Grimes JM, Hilgenfeld R, Jansson AM, Malet H, Mancini EJ, Mastrangelo E, Mattevi A, Milani M, Moureau G, Neyts J, Owens RJ, Ren J, Selisko B, Speroni S, Steuber H, Stuart DI, Unge T, Bolognesi M. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 2010; 87: 125-148
- 4 Malet H, Massé N, Selisko B, Romette JL, Alvarez K, Guillemot JC, Tolou H, Yap TL, Vasudevan S, Lescar J, Canard B. The flavivirus polymerase as a target for drug discovery. Antiviral Res 2008; 80: 23-35
- 5 Cerutti H, Casas-Mollano JA. On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet 2006; 50: 81-99
- 6 Coulerie P, Eydoux C, Hnawia E, Stuhl L, Maciuk A, Lebouvier N, Canard B, Figadère B, Guillemot JC, Nour M. Biflavonoids of Dacrydium balansae with potent inhibitory activity on Dengue 2 NS5 polymerase. Planta Med 2012; 78: 672-677
- 7 Noble CG, Shi PY. Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res 2012; 96: 115-126
- 8 Hodges R. 5,5′-dihydroxy-7,4′,7′′,4′′′-tetramethoxy-8,3′′-biflavone from Dacrydium cupressinum Lamb. Aust J Chem 1965; 18: 1491-1492
- 9 Markham RK, Sheppard C, Geiger H. 13C NMR studies of some naturally occurring amentoflavone and hinokiflavone biflavonoids. Phytochemistry 1987; 26: 3335-3337
- 10 Ilyas N, Ilyas M, Rahman W, Okigawa M, Kawano N. Biflavones from the leaves of Araucaria excelsa . Phytochemistry 1978; 17: 987-990
- 11 Kim J, Park K, Lee C, Chong Y. Synthesis of a complete series of O-methyl analogues of Naringenin and Apigenin. Bull Korean Chem Soc 2007; 28: 2527-2530
- 12 Lin YM, Chen FC, Lee KH. Hinokiflavone, a cytotoxic principle from Rhus succedanea and the cytotoxicity of the related biflavonoids. Planta Med 1989; 55: 166-168
- 13 Lin YM, Zembower DE, Flavin MT, Schure RM, Anderson HM, Korba BE, Chen FC. Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro . Bioorg Med Chem Lett 1997; 7: 2325-2328
- 14 Molfetta FA, Honório KM, Alves CN, Da Silva ABF. A study on the anti-HIV activity of biflavonoid compounds by using quantum chemical and chemometric methods. J Mol Struct 2004; 674: 191-197
- 15 Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JYH, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL, Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller TH, Shi PY. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A 2009; 106: 20435-20439
- 16 Niyomrattanakit P, Chen YL, Dong H, Yin Z, Qing M, Glickman JF, Lin K, Mueller D, Voshol H, Lim JYH, Nilar S, Keller TH, Shi PY. Inhibition of Dengue virus polymerase by blocking of the RNA tunnel. J Virol 2010; 84: 5678-5686